BRPI1006260A2 - solução para hemodiálise peritoneal compreendendo um ou mais compostos de creatina - Google Patents

solução para hemodiálise peritoneal compreendendo um ou mais compostos de creatina

Info

Publication number
BRPI1006260A2
BRPI1006260A2 BRPI1006260A BRPI1006260A BRPI1006260A2 BR PI1006260 A2 BRPI1006260 A2 BR PI1006260A2 BR PI1006260 A BRPI1006260 A BR PI1006260A BR PI1006260 A BRPI1006260 A BR PI1006260A BR PI1006260 A2 BRPI1006260 A2 BR PI1006260A2
Authority
BR
Brazil
Prior art keywords
peritoneal
creatine compounds
hemodialysis solution
hemodialysis
solution
Prior art date
Application number
BRPI1006260A
Other languages
English (en)
Inventor
Michael Möddel
Theo Wallimann
Original Assignee
Crearene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crearene Ltd filed Critical Crearene Ltd
Publication of BRPI1006260A2 publication Critical patent/BRPI1006260A2/pt
Publication of BRPI1006260B1 publication Critical patent/BRPI1006260B1/pt
Publication of BRPI1006260B8 publication Critical patent/BRPI1006260B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

abstract not avaible
BRPI1006260A 2009-04-06 2010-03-10 soluções para hemodiálise e diálise peritoneal compreendendo um ou mais compostos de creatina BRPI1006260B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09005038.6 2009-04-06
EP09005038 2009-04-06
PCT/CH2010/000065 WO2010115291A1 (en) 2009-04-06 2010-03-10 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds

Publications (3)

Publication Number Publication Date
BRPI1006260A2 true BRPI1006260A2 (pt) 2017-01-17
BRPI1006260B1 BRPI1006260B1 (pt) 2020-11-17
BRPI1006260B8 BRPI1006260B8 (pt) 2021-05-25

Family

ID=42111284

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006260A BRPI1006260B8 (pt) 2009-04-06 2010-03-10 soluções para hemodiálise e diálise peritoneal compreendendo um ou mais compostos de creatina

Country Status (13)

Country Link
US (2) US9248112B2 (pt)
EP (1) EP2416770B1 (pt)
JP (1) JP6130666B2 (pt)
CN (1) CN102421431B (pt)
AU (1) AU2010234206B2 (pt)
BR (1) BRPI1006260B8 (pt)
CA (1) CA2757327C (pt)
EA (1) EA025137B1 (pt)
ES (1) ES2615204T3 (pt)
IL (1) IL215504A (pt)
PL (1) PL2416770T3 (pt)
WO (1) WO2010115291A1 (pt)
ZA (1) ZA201107715B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102573828B (zh) * 2009-07-24 2018-02-23 克雷勒内有限公司 通过施用肌酸化合物的透析患者中的细胞保护
ES2382513B2 (es) * 2012-05-07 2012-09-24 Luiz Guilherme STARK AROEIRA Solución de diálisis que contiene al menos un antagonista de CCR2
CN102973599B (zh) * 2012-12-13 2014-04-23 天津金耀集团有限公司 腹膜透析液（乳酸盐）组合物
WO2014197806A2 (en) * 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
PL3429657T3 (pl) 2016-03-14 2022-08-22 Advitos Gmbh Systemy albo aparatury dla przeprowadzania dializy
SG11201900588YA (en) * 2016-08-11 2019-02-27 Cellix Bio Private Ltd Compositions and methods for the treatment of irritable bowel syndrome
EP3600347A1 (en) * 2017-03-28 2020-02-05 Advitos GmbH Compositions and methods for regenerating carrier protein-containing multiple pass albumin dialysis fluid
IL270771B2 (en) 2017-05-22 2023-12-01 Advitos Gmbh Methods and systems for removing carbon dioxide
WO2019079765A1 (en) * 2017-10-20 2019-04-25 University Of Georgia Research Foundation, Inc. SURFACES AND COATING COMPOSITIONS COMPRISING ANTIFOULING, ANTITHROMBOTIC AND ANTIBACTERIAL PROPERTIES AND METHODS OF PREPARATION THEREOF
CN107890568A (zh) * 2017-10-31 2018-04-10 华仁药业股份有限公司 一种低危害的血液滤过置换液及其制备工艺
KR101864384B1 (ko) * 2017-12-11 2018-06-04 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 쥐남의 치료, 개선 또는 예방용 조성물 및 방법
GB201801633D0 (en) * 2018-02-01 2018-03-21 Ogorman Edward Sports supplements based on liquid creatine
CA3113377A1 (en) 2018-10-11 2020-04-16 Sanifit Therapeutics S.A. Inositol phosphates for the treatment of ectopic calcification
CN114903998A (zh) * 2021-02-07 2022-08-16 大连医科大学附属第二医院 渗透压保护防治腹膜纤维化和超滤衰竭
WO2026011268A1 (de) * 2024-07-08 2026-01-15 Crearene Ag Kreatinverbindung zur prophylaxe und behandlung des kreatinmangels und den damit verbundenen symptomen in hämodialyse-patienten
WO2026011269A1 (de) * 2024-07-08 2026-01-15 Crearene Ag Dosierungsformulierung für eine dialyselösung zur prophylaxe und behandlung des kreatinmangels und den damit verbundenen symptomen in peritonealdialyse-patienten
WO2026011267A1 (de) * 2024-07-08 2026-01-15 Crearene Ag Dialyselösung zur verwendung bei der prophylaxe und behandlung des kreatinmangels in patienten

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604379A (en) * 1984-06-18 1986-08-05 Curators Of The University Of Missouri Dialysis solutions containing cross-linked gelatin
FR2614219B1 (fr) * 1987-04-23 1993-07-09 Materiels Annexes Dialyse Procede de fabrication de granules destines a la preparation de solutions de dialyse et installation pour sa mise en oeuvre.
US5827820A (en) * 1992-04-06 1998-10-27 Baxter International Inc. Aqueous peritoneal dialysis solution
ATE332127T1 (de) 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
EP0854712B1 (en) 1995-10-11 2003-05-07 Avicena Group, Inc. Use of creatine analogues for the treatment of disorders of glucose metabolism
ATE424467T1 (de) * 1999-05-11 2009-03-15 Cellfree Sciences Co Ltd Zubereitung, die einen zellextrakt zur herstellung eines zellfreien proteins enthalten und vorrichtung zur herstellung eines zellfreien proteins
AU5636300A (en) 1999-06-25 2001-01-31 Avicena Group, Inc. Use of creatine or creatine analogs for the prevention and treatment of transmissible spongiform encephalopathies
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US20030013767A1 (en) * 2001-07-13 2003-01-16 Samuel Bessman Method of treating weight loss using creatine
EP1567180A4 (en) 2002-06-04 2010-03-10 Avicena Group Inc METHOD FOR THE TREATMENT OF COGNITIVE DYSFUNCTION BY MODULATING THE CHANGE OF ENERGY REPLACEMENT IN THE BRAIN
AU2007249847A1 (en) 2006-05-11 2007-11-22 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
WO2007133731A2 (en) 2006-05-11 2007-11-22 Avicena Group, Inc. Creatine-ligand compounds and methods of use thereof
DE102006050931A1 (de) * 2006-10-28 2008-04-30 Alzchem Trostberg Gmbh Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
US20080206170A1 (en) 2006-12-07 2008-08-28 Belinda Tsao Nivaggioli Creatine compositions for skin treatment
WO2008124151A2 (en) 2007-04-09 2008-10-16 Avicena Group, Inc. Use of creatine compounds for the treatment of eye disorders
WO2008137137A1 (en) 2007-05-03 2008-11-13 Avicena Group, Inc. Creatine ascorbyl derivatives and methods of use thereof
US20090105196A1 (en) 2007-06-22 2009-04-23 Belinda Tsao Nivaggioli Use of creatine compounds to treat dermatitis

Also Published As

Publication number Publication date
AU2010234206A1 (en) 2011-11-03
IL215504A (en) 2017-04-30
JP6130666B2 (ja) 2017-05-17
CN102421431A (zh) 2012-04-18
HK1164157A1 (en) 2012-09-21
JP2012522812A (ja) 2012-09-27
PL2416770T3 (pl) 2017-06-30
AU2010234206A2 (en) 2011-11-10
ES2615204T3 (es) 2017-06-05
AU2010234206B2 (en) 2016-10-27
EA025137B1 (ru) 2016-11-30
US20160120829A1 (en) 2016-05-05
CA2757327C (en) 2017-12-12
EP2416770B1 (en) 2016-10-26
IL215504A0 (en) 2011-12-29
EP2416770A1 (en) 2012-02-15
CA2757327A1 (en) 2010-10-14
WO2010115291A1 (en) 2010-10-14
BRPI1006260B8 (pt) 2021-05-25
EA201101463A1 (ru) 2012-03-30
US9248112B2 (en) 2016-02-02
ZA201107715B (en) 2012-07-25
CN102421431B (zh) 2019-04-02
US20120101069A1 (en) 2012-04-26
BRPI1006260B1 (pt) 2020-11-17

Similar Documents

Publication Publication Date Title
BRPI1006260A2 (pt) solução para hemodiálise peritoneal compreendendo um ou mais compostos de creatina
BRPI0917238A2 (pt) sensores em linha para aplicações de diálises
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
EA201400178A1 (ru) Лечение рака молочной железы
CR20140576A (es) Sintesis de compuestos heterociclicos
EA201390074A1 (ru) 5-хлор-4-гидрокси-1-метил-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид, его соли и применения
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
BRPI0721897A2 (pt) Dialisado peritoneal
CR20130539A (es) Triazolopiridinas
EP2914322A4 (en) Quiet nasal cannula
BR112015002803A2 (pt) sistema de campo para uma mesa cirúrgica
CR20150132A (es) Profármacos de aminoquinazolina inhibidora de cinasa
BRPI1016190A2 (pt) compostos farmacêuticos.
BR112014007980A2 (pt) máquina de diálise peritonial
PL2211874T3 (pl) Sterylizowane roztwory dializacyjne zawierające pirofosforan
FR2995214B1 (fr) Solution a viscosite reduite de proteine a concentration elevee
BRPI1007686A2 (pt) sistema de iluminação
EP2535065A4 (en) DIALYSIS MACHINE
UA115373C2 (uk) Стабільний рідкий склад amg 416 (велкалсетиду)
BR112013015429A2 (pt) conjunto de conexão para bombas submersíveis transportadas através de tubulação
CL2009001973S1 (es) Mostrador.
FR2984432B1 (fr) Unite de roulement.
CL2014002817A1 (es) Compuesto monoclorhidrato de anamorelina que tiene contenido controlado de cloruro; composicion que lo comprende; procedimiento de preparacion del compuesto.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: CREARENE AG (CH)

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF